Morgan Stanley is lowering its estimates on MedcoHealth Solutions Inc. MHS.
“We lowered our 2012 EPS estimate to $4.72 and our 2013 EPS estimate to $5.50 to reflect the loss of the FEP at mail contract, which covered 9.8 million mail scripts with $3 billion in revenues,” Morgan Stanley writes.
MedcoHealth close Friday at $58.66.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in